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Researchers explore why the effectiveness 
of the immune system declines with age 
Is it possible to bolster the immune 
systems of elderly individuals, and in so 
doing reduce the increased risks of 
cancer and other ailments that 
accompany old age? 
Members of the Hubert H. Humphrey 
Cancer Research Center are among 
scientists nationwide who are doing basic 
research into age-related immune 
changes that could help to answer that 
question. 
There's no doubt that the immune 
system's effectiveness declines with age, 
says Richard A. Miller, M.D., Ph.D., a 
Humphrey Center member and a 
professor of pathology at Boston 
University School of Medicine. The 
important white cells called T cells are a 
particular interest of Dr. Miller's. ("T" 
stands for thymus, and reflects the fact 
that these white cells become targeted to 
specific disease-causing agents in the 
thymus gland, which is located in the 
neck.) T-cell production undergoes a 
decline that actually begins in childhood, 
says the scientist. 
"The number of T cells that leave the 
thymus is highest in newborns and young 
children," he notes, "and by the time 
someone reaches young adulthood it has 
declined roughly tenfold." 
This decline, which apparently 
continues into old age, is only one of 
several age-related changes. The T-cell 
population in older individuals is much 
^ more heavily weighted towards 
\" cells—^those that have already 
encountered the specific type of virus, 
bacteria, or diseased cell they're targeted 
to attack—than are the T cells in young 
Richard A. Miller, M.D., Ph.D., studies 
age-related changes in the immune system. 
(Photo by Bradford F. Herzog) 
people. Researchers have also shown 
that T cells in the elderly lose some 
capacity to secrete interleukin-2, a 
substance whose role is activating other 
white cells. 
One of Dr. Miller's main research 
goals is to pinpoint still other age-related 
changes by comparing cells from older 
rodents with cells from young animals. 
"We've found that the cells from older 
animals are less able to increase their 
calcium levels," he notes. "That's 
important, because calcium is required 
for all sorts of cellular activities." 
Such findings don't necessarily 
explain the fact that cancer is, for the 
most part, a disease of the elderly. Other 
considerations undoubtedly play a role, 
including the fact that many cancers can 
continued on page 2 
Growing evidence 
suggests depression 
poses little if any 
risk of cancer 
If scientific studies often seem to be the 
source of disturbing news about cancer, 
such studies can sometimes produce 
reassuring results, too. 
That's the case with a series of recent 
studies focusing on whether individuals 
with symptoms of depression face a 
higher cancer risk than those who aren't 
depressed. 
The latest of these epidemiological 
studies, carried out by a group of 
scientists at the National Institute on 
Aging in Baltimore, involved checking 
cancer patterns among more than 6,400 
individuals across the nation who were 
first tested for signs of depression in the 
1970s. 
According to Bernard H. Fox, Ph.D., a 
member of the Hubert H. Humphrey 
Cancer Research Center and a professor 
of psychiatry at Boston University 
School of Medicine, the researchers 
found that the depressed individuals had 
no greater risk of cancer than those 
without symptoms of depression. That 
finding, combined with those of other 
studies, largely puts to rest the idea that 
depression is a significant risk factor for 
cancer, says Dr. Fox. 
"It's likely that the relationship 
between depressive symptoms and later 
cancer is at best weak, and may indeed be 
non-existent," says Dr. Fox, an expert on 
the connections between mental states 
and cancer. 
continued on page 3 
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Steven H. Zeisel, M.D., PhD., discusses the role of diet in the formation of nitrosamines. 
(Photo by Bradford F. Herzog) . .^...^....-^-^^^ ^^ 
Humphrey Center group is exploring how 
cancer-causing nitrosamines are formed 
Immune System 
continued from page 1 
grow for years before they begin causing 
symptoms. 
Still, the evidence that the immune 
system is involved in controlling cancer 
is quite convincing, says Dr. Miller. 
"There's a reasonable likelihood that at 
least some forms of malignant tumors are 
sought out and destroyed in the early 
stages by the immune system," he says. 
Even as scientists continue seeking to 
understand the nature of the immune 
system's role in attacking tumors, the 
first efforts are being made to strengthen 
the immune system's ability to combat 
advanced cancers. Dr. Miller notes that 
physicians at several medical centers are 
exploring whether interleukin-2, in 
combination with white cells, can shrink 
or eliminate tumors. 
Yet even if such efforts yield 
encouraging results, it could still be some 
time before scientists feel they know 
enough about the immune system to try 
enhancing the system's effectiveness in 
older individuals as a shield against 
cancer and other diseases. Nevertheless, 
says the researcher, the idea is 
increasingly viewed as a realistic 
prospect. 
One approach, he says, would be to 
find ways to boost the levels of 
interleukin-2 and other immune-system 
agents in elderly populations. As a 
prelude to such a strategy, says the 
researcher, scientists are working to 
overcome interleukin-2's natural 
tendency to break down in the 
bloodstream. 
"An equally promising approach," 
says Dr. Miller, "is to learn enough about 
how the immune system produces good, 
functioning immune cells to allow us to 
stimulate the system in an elderly person 
to produce more of these cells. I think 
it's likely that something along these 
lines will be ready in a decade or two." 
A decade or so ago, sodium nitrite was 
the focus of intense news media attention. 
The coverage was the result of 
findings that the substance, used as a 
preservative in bacon, hot dogs and other 
products, is a precursor for powerful 
cancer-causing agents. Once consumed, 
scientists reported, the nitrite part of the 
compound bonds with other chemicals in 
the body to form substances called 
nitrosamines. And these, research 
suggested, can cause many different 
kinds of cancer. 
Though the publicity has long since 
subsided, the concern is still very much 
alive, says Steven H. Zeisel, M.D., Ph.D., 
a Hubert H. Humphrey Cancer Research 
Center member and an ^sociate 
professor of pathology and pediatrics at 
Boston University School of Medicine. 
"Nobody in the field would question that 
nitrosamines are among the most potent 
carcinogens known," he says. 
Animal experiments show that even in 
small doses, nitrosamines can trigger 
cancer. In humans, the impact of the 
substances is less clear-cut, mainly 
because it's unethical to do experiments 
that involve giving people potentially 
dangerous agents. Still, says Dr. Zeisel, 
there's strong evidence that the 
nitrosamines in tobacco smoke are a 
major cause of oral cancer, and there is 
strong suspicion that the substances play 
a role in many other types of cancer as 
well. 
Though the situation might seem to 
point to a need for a ban on sodium 
nitrite, such a move isn't practical right 
now, says Dr. Zeisel. "We don't have 
good alternatives," he says, "and given a 
choice between the long-term risk of 
cancer and the immediate threat of 
botulism, public-health people have 
decided we've got to keep using these 
preservatives." 
Another strategy, though, is to look 
for ways to slow the formation of 
nitrosamines in the body. Dr. Zeisel and 
his associates are doing research that 
could help reveal whether such a strategy 
makes sense. 
His group is focusing on the "-amines" 
part of nitrosamines. Specifically, 
they're trying to find out how the body 
makes these substances, known T 
technically as methylamines. 
One source of methylamine is choline, 
a substance present in many foods. 
Methylamine emerges in the intestines 
when bacteria that are harbored there 
break down the choline we consume. 
It would be very tough to cut down on 
choline consumption, says Dr. Zeisel, and 
it wouldn't make sense in any case. "We 
have to consume a certain amount of 
choline," says the scientist. "Our bodies 
need it to form cell membranes and to 
make the neurotransmitter, acetylcholine." 
A more direct source of methylamine, 
though, is fish. Indeed, says Dr. Zeisel, 
it's these substances that give fish their 
distinctive odor. The scientist and his 
associates have discovered that when we 
consume fish, it can markedly raise our 
continued on next page 
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Nitrosamines 
continued from previous page 
/ody levels of methylamines. "We fed 
five volunteers a diet that was very high 
in fish," notes the scientist, "and 
compared methylamine levels in their 
urine to the levels when they were on a 
non-fish diet. The increase resulting 
from the fish was quite dramatic." 
Such findings don't mean consumers 
should start cutting down on fish, 
particularly in light of the recent 
discovery that certain oils in fish may 
help protect against heart attacks. On the 
other hand, says the scientist, the findings 
do suggest the need to explore the body's 
systems for handling nitrite, its close 
cousin nitrate, and methylamine. 
"If most of our exposure to 
methylamine comes from internal 
processes," says the scientist, "then 
changing the amount of fish we eat 
wouldn't matter much. On the other 
hand, if it should turn out that fish or 
other components of the diet are a major 
source of these substances, we might 
have to think about dietary changes." 
One of his group's goals is to explore 
whether the liver is a major producer of 
^nethylamines, since determining that 
ould help resolve the issue of how 
ifiuch diet matters. Until more is 
understood about this process, though. 
Dr. Zeisel says that simple prudence 
dictates keeping our consumption of 
foods that may boost the formation of 
nitrosamines at moderate levels. 
That applies to fish, he says, and it 
also applies to foods preserved with 
sodium nitrite. "The extra exposure you 
get from eating something like a hot dog 
or a piece of bacon probably isn't that 
great," he says, "but if you eat significant 
amounts of those foods every day, you 
might be substantially increasing your 
exposure." 
Depression 
continued from page 1 
Yet the scientist, who wrote an 
accompanying commentary for the 
journal that carried the results of the 
latest study, says that while the 
cumulative weight of scientific evidence 
points to a lack of any cancer-depression 
link, the issue isn't closed. Some 
anomalies in the studies leave open the 
possibility there's a modest connection of 
some type, says Dr. Fox. 
For example, says the scientist, it's 
possible that individuals with signs of 
depression are at an increased risk of 
cancer, but that the increase is so slight it 
can't be readily measured by the kinds of 
studies done to date. "Another 
possibility," he says, "is that there may be 
subgroups with a particular susceptibility 
to depression-associated cancers." 
Dr. Fox, while emphasizing that 
there's no evidence as yet to support 
either theory, says that there is evidence 
that depression can alter the immune 
system. The evidence, he says, comes 
from studies of patients with depression 
severe enough to require hospitalization. 
"Severe depression," says the scientist, 
"is known to bring about an increase in 
the hormones called corticosteroids in 
about half the patients affected." The rise 
in hormones, he adds, suppresses the 
activity of certain types of 
disease-fighting white cells. 
According to Dr. Fox, something^ 
similar could be affecting a smaller 
proportion of individuals who are less 
severely depressed, though presumably 
the hormonal increases in such 
individuals—and therefore the effects on 
their white cells—would not be as great. 
Even if some mildly depressed people 
do have impaired immune systems, though, 
the scientist notes that there's little direct 
evidence linking the suppression of 
subgroups of white cells to cancer in 
humans. One of the few signs of such a 
link, he adds, is the fact that AIDS patients, 
in whom certain types of white cells 
become diseased, are prone to a rare form 
of cancer known as Kaposi's sarcoma. 
Dr. Fox emphasizes that, given the 
tenuous nature of the evidence for any kind 
of a depression-cancer link, the principal 
need at this point is for additional research 
into the matter. Meanwhile, he says, 
depression-prone individuals needn't 
concern themselves with the possibility 
that their mental state may be increasing 
their cancer risks. 
"If there is a link between depressive 
symptoms and cancer in some individuals, 
it's probably a weak one," notes Dr. Fox, 
"so my advice to people is that they just 
not worry about it." 
QUESTIONS... 
Answer to question on back panel. 
A • The rates of two types of cancer 
have dropped markedly over recent 
decades. One is stomach cancer. The 
other is uterine cancer, which includes 
cancer of the cervix and cancer of the 
uterus. 
The American Cancer Society 
estimates that uterine cancer will claim 
about 10,000 lives this year, which 
represents a drop of 70 percent over four 
decades. Stomach cancer will claim 
about 13,000 lives, representing a fall-off 
of similar magnitude. 
In the case of uterine cancer, the main 
reason for the drop-off is the Pap test, in 
which a sample taken from the mucous 
membrane of the cervix can reveal early 
signs of cancer. 
Scientists don't know what accounts 
for the progress against stomach cancer, 
but suspect that one factor may be an 
increased consumption of frozen as 
opposed to canned foods. 
What is an oncogene? 
A • An oncogene is a normal gene that 
has been altered in one way or another so 
that it no longer works normally. Some 
oncogenes, for example, have undergone 
changes in structure. Others appear in 
excessive quantities in cells. 
More than 50 oncogenes have been 
identified so far. Not all of these have 
been linked to human cancer, however. 
In most instances, the versions of the 
oncogenes identified have been those 
found in viruses or in animal tumors, not 
in human tumors. 
Scientists believe that the normal 
versions of most oncogenes are involved 
in cell growth or differentiation. When 
the genes are altered or multiplied, it sets 
the stage for uncontrolled growth. 
Scientists have also found, though, that it 
usually takes at least two oncogenes to 
make a cell cancerous. And still further 
steps may be needed to enable a tumor to 
mature and begin spreading to new sites 
in the body. 
Scientists hope that identifying 
oncogenes will eventually lead to new 
strategies for controlling malignant 
growth. 
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CANCER NOTES 
CANCER NOTE: Cancer of the 
pancreas is one of the most lethal forms of 
the disease. Patients with this cancer, 
which claims an estimated 25,000 lives 
annually, have only about a 4-percent 
five-year survival rate, compared to a 
13-percent rate for those with lung cancer. 
Scientists are working hard to develop 
more effective treatments for pancreatic 
cancer. 
CANCER NOTE: Physicians are 
increasingly trying combined forms of 
therapy in treating cancer. In one such 
combination, tumors are treated with heat, 
which weakens the cells, before the 
application of radiation or drugs. 
CANCER NOTE: Vitamin C is thought 
to prevent the forming of nitrosamines. 
which are potent cancer-causing agents. 
(See article on page 2). There's no 
evidence, however, that massive doses of 
the vitamin protect against cancer. The 
American Cancer Society recommends 
including ample amounts of vitamin C in 
the diet by consuming foods like citrus 
fruit, but advises against taking large 
quantities of vitamin C supplements. 
CANCER NOTE: The treatment of 
testicular cancer is a major success story. 
It's estimated that more than 90 percent of 
the 5,700 Americans expected to be 
afflicted by that form of cancer in 1989 
will survive at least five years. That 
compares to just over 60 percent 20 years 
ago. New diagnostic techniques and 
therapies are the main reason for the 
improved outlook. 
CANCER NOTE: The main factor that 
increases a woman's risk of ovarian 
cancer is advancing age. Most women 
who contract the disease are 65 or older. 
Women who haven't had children are at a 
somewhat higher risk for the disease than 
mothers, and women who have taken 
birth-control pills seem to hold a slight 
advantage over those who haven' t. 
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Richard P. Anthony. "Cancer Notes" 
information is provided courtesy of the — 
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Humphrey Center member Nadia Rosenthal, 
Ph.D., right, an assistant professor of 
biochemistry, recently received a grant 
from Aid for Cancer Research (ACR) to 
support her research in the regulation of 
gene expression in animal muscle cells. With 
the grant. Dr. Rosenthal was able to 
purchase a laminar flow hood. Shown here 
with Dr. Rosenthal are ACR presentation 
chairperson Barbara Goodman-Oray and 
Herbert Wotiz, Ph.D., director of the 
Humphrey Center. (Photo by David 
Keough, BUSM Educational Media Support 
Center) 
What types of cancer 
have declined most? 
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